Cervical cancer

Self-sampling to increase participation in cervical cancer screening: an RCT comparing home mailing, distribution in pharmacies, and recall letter
A 3-year interval is too short for re-screening women testing negative for human papillomavirus: a population-based cohort study
Cervical cancer screening in immigrant women in Italy: a survey on participation, cytology and histology results
Changes in cervical cancer incidence following the introduction of organized screening in Italy
Combined use of cytology, p16 immunostaining and genotyping for triage of women positive for high-risk human papillomavirus at primary screening.
Esito clinico delle lesioni CIN2 trattate
Five-year risk of CIN3 after short-term HPV-DNA negativity in cytology-negative women: a population-based cohort study
HPV genotyping for the cross-sectional and longitudinal probability of developing CIN2
Impact of variations in triage cytology interpretation on human papillomavirus-based cervical screening and implications for screening algorithms
Implementation of DNA-HPV primary screening in Italian cervical cancer screening programmes. Results of the MIDDIR Project
Indicators for monitoring screening programs with primary hpv test
Informed cytology for triaging HPV-positive women: substudy nested in the NTCC randomized controlled trial
Long-Term Clinical Outcome after Treatment for High-Grade Cervical Lesions: a Retrospective Monoinstitutional Cohort Study
Nuove Tecnologie per il cancro della Cervice 2 (NTCC2): disegno dello studio e andamento del reclutamento
Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study
Risk of CIN2 or more severe lesions after negative HPV-mRNA E6/E7 overexpression assay and after negative HPV-DNA test: Concurrent cohorts with a 5-year follow-up
Screening women for cervical cancer carcinoma with a HPV mRNA test: first results from the Venice pilot program
Studio pilota sul non trattamento immediato delle lesioni CIN2
Trends in net survival from cervical cancer in six European Latin countries: results from the SUDCAN population-based study